Compare NTST & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTST | IRMD |
|---|---|---|
| Founded | 2019 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2014 |
| Metric | NTST | IRMD |
|---|---|---|
| Price | $20.16 | $100.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $20.27 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 1.7M | 71.2K |
| Earning Date | 02-10-2026 | 02-10-2026 |
| Dividend Yield | ★ 4.36% | 0.80% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | 0.08 | ★ 1.75 |
| Revenue | ★ $195,006,000.00 | $83,814,000.00 |
| Revenue This Year | $20.93 | $10.85 |
| Revenue Next Year | $10.80 | $3.72 |
| P/E Ratio | $245.16 | ★ $57.03 |
| Revenue Growth | ★ 19.79 | 14.43 |
| 52 Week Low | $13.74 | $47.48 |
| 52 Week High | $20.25 | $107.90 |
| Indicator | NTST | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 72.52 | 52.19 |
| Support Level | $18.70 | $98.90 |
| Resistance Level | $19.64 | $107.90 |
| Average True Range (ATR) | 0.48 | 3.78 |
| MACD | 0.11 | 0.10 |
| Stochastic Oscillator | 97.94 | 44.47 |
Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.